We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVC
2126
DELISTED
Invacare Corporation
IVC
| $566K | ﹤0.01% |
47,950
-810
| -2% | -$12.3K |
|
2127
Clean Energy Fuels
CLNE
$412M
| $565K | ﹤0.01% |
72,372
-100
| -0.1% | -$978 |
|
|
CAJ
2128
DELISTED
Canon, Inc.
CAJ
| $565K | ﹤0.01% |
17,347
| – | – |
|
2129
AMC Entertainment Holdings
AMC
$2.39B
| $564K | ﹤0.01% |
2,455
-17
| -0.7% | -$4.01K |
|
2130
Bausch Health
BHC
$2.41B
| $564K | ﹤0.01% |
4,300
-100
| -2% | -$11.9K |
|
|
TDAY
2131
USA Today Co
TDAY
$1.32B
| $564K | ﹤0.01% |
33,936
+300
| +0.9% | +$4.74K |
|
|
ENOC
2132
DELISTED
EnerNOC, Inc.
ENOC
| $563K | ﹤0.01% |
33,213
+10
| +0% | +$187 |
|
2133
OneSpan
OSPN
$601M
| $562K | ﹤0.01% |
29,907
| – | – |
|
2134
Center Bancorp
CNOB
$1.69B
| $561K | ﹤0.01% |
29,442
+7,378
| +33% | +$142K |
|
|
NEWS
2135
DELISTED
NewStar Financial, Inc.
NEWS
| $560K | ﹤0.01% |
49,792
| – | – |
|
2136
Option Care Health
OPCH
$3.55B
| $559K | ﹤0.01% |
20,217
-12
| -0.1% | -$372 |
|
|
SMA
2137
DELISTED
SYMMETRY MEDICAL INC
SMA
| $559K | ﹤0.01% |
55,367
| – | – |
|
2138
TC Energy
TRP
$68.1B
| $557K | ﹤0.01% |
10,810
| – | – |
|
2139
Sabre
SABR
$838M
| $555K | ﹤0.01% |
30,997
+1,807
| +6% | +$34K |
|
2140
Sonida Senior Living
SNDA
$1.83B
| $555K | ﹤0.01% |
1,744
-5
| -0.3% | -$1.75K |
|
|
NM
2141
DELISTED
Navios Maritime Holdings Inc.
NM
| $555K | ﹤0.01% |
9,250
| – | – |
|
|
FNBC
2142
DELISTED
First NBC Bank Holding Company
FNBC
| $555K | ﹤0.01% |
16,933
-400
| -2% | -$13K |
|
|
FRAN
2143
DELISTED
Francesca's Holdings Corporation
FRAN
| $554K | ﹤0.01% |
3,312
-9
| -0.3% | -$1.49K |
|
2144
Deutsche Bank
DB
$70.4B
| $552K | ﹤0.01% |
17,726
| – | – |
|
|
GTIV
2145
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $551K | ﹤0.01% |
32,839
+320
| +1% | +$5.6K |
|
2146
Standard BioTools
LAB
$321M
| $550K | ﹤0.01% |
22,450
-100
| -0.4% | -$2.81K |
|
2147
MiMedx Group
MDXG
$622M
| $550K | ﹤0.01% |
77,088
-500
| -0.6% | -$3.48K |
|
|
ATRI
2148
DELISTED
Atrion Corp
ATRI
| $550K | ﹤0.01% |
1,804
| – | – |
|
2149
CorVel
CRVL
$3.01B
| $548K | ﹤0.01% |
48,276
-1,050
| -2% | -$14.2K |
|
2150
Precigen
PGEN
$2.33B
| $547K | ﹤0.01% |
30,798
-1,904
| -6% | -$38.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.